Impact of Asthma Exacerbations
Overview
The purpose of the study is to gain a deeper understanding of the impact of asthma attacks on the lives of patients who experience them. This will help us to describe the true extent of the impact of asthma attacks on factors of importance to patients which have not previously been well described, including the psychological, social, financial and emotional burden of asthma attacks. Additionally, it is hoped that detailed questioning regarding features of asthma attacks from a patient perspective will improve our understanding of patient recognition of attacks, consistency of certain features of attacks and patient views regarding preventative strategies for attacks. Patient experiences of asthma attacks are poorly described in previous research. Hence this work is expected to provide useful insights into these experiences which will contribute to improvements in detecting, treating and preventing asthma attacks. The study will consist of a one-off interview lasting about 45 minutes with patients who have recently had asthma attacks. We plan to recruit patients for the study from an outpatient clinic for those who have had a recent attack or from a register of patients who have volunteered for future asthma research studies. The interviews will take place in person at the Respiratory Research Unit at the Nottingham City Hospital or over the telephone depending on patient preference.
Full Title of Study: “Impact of Asthma Exacerbations: A Qualitative Study”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: September 2020
Interventions
- Other: Interview
- Semi-structured 45 minute interviews regarding impact of asthma attacks
Arms, Groups and Cohorts
- Asthma with recent (<4/52) asthma attack
Clinical Trial Outcome Measures
Primary Measures
- Thematic analysis of interview transcripts using framework approach
- Time Frame: One off 45 minute interview
- Thematic analysis of interview transcripts using framework approach
Participating in This Clinical Trial
Inclusion Criteria
- Adults with previous clinician diagnosis of asthma (16 years and above) – Recent (≤4 weeks) asthma attack for which patient received ≥3 days of systemic corticosteroid treatment Exclusion Criteria:
- Anyone under the age of 16 years. – Anyone unable to speak or understand English.
Gender Eligibility: All
Minimum Age: 16 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University of Nottingham
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.